Dow Up0.09% Nasdaq Down0.02%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
8.23 Up 0.74(9.88%) Aug 27, 4:00PM EDT
|After Hours : 8.50 Up 0.27 (3.28%) Aug 27, 7:59PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.9
Mean Recommendation (last week):1.9
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:11.33
Median Target:12.00
High Target:15.00
Low Target:6.00
No. of Brokers:6

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jun 12, 2014UBSInitiated Buy
May 29, 2012RBC Capital MktsUpgradeSector PerformOutperform
Apr 13, 2012Cantor FitzgeraldInitiated Buy
Mar 6, 2012Canaccord GenuityInitiated Buy
Oct 11, 2011RBC Capital MktsDowngradeOutperformSector Perform
Dec 20, 2010RBC Capital MktsUpgradeSector PerformOutperform
Jan 27, 2009Rodman & RenshawDowngradeMkt OutperformMkt Perform
Aug 12, 2008Piper JaffrayInitiated Buy
Jun 4, 2008Cantor FitzgeraldDowngradeBuyHold
Jan 5, 2007Rodman & RenshawInitiated Mkt Outperform

More Upgrades & Downgrades for SNSS

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy2333
Buy5554
Hold1111
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.